John J Herr, R.Ph. is a distinguished pharmacist and esteemed Fellow of the Alliance for Pharmacy Compounding. With a wealth of experience, John is the proud owner of Town & Country Compounding, located in Ramsey, NJ. His commitment to excellence and dedication to advancing the field of pharmaceutical compounding make him a valued figure within the industry. Town & Country Compounding stands as a testament to John's unwavering passion for delivering high-quality pharmaceutical solutions. As a fully accredited compounding laboratory, holding certifications such as USP 795/795 and 800 for both sterile and non-sterile compounding, the facility exemplifies John's exacting standards and commitment to precision. With licensure in approximately 25 states, Town & Country Compounding has earned a well-deserved reputation for excellence in providing patient-specific medications. John's collaborative efforts with Integrative Practitioners have led to the delivery of sterile and non-sterile medications directly to patients or provider sites, contributing to enhanced patient care and positive health outcomes. John's visionary leadership extends beyond the confines of traditional compounding practice. Town & Country Compounding is actively engaged in conducting Clinical Trials on an international scale, a testament to John's forward-thinking approach and dedication to advancing pharmaceutical research. Through collaborative efforts in formulation development and participation in Phase I and Phase II Trials, John and his team continue to make strides in shaping the future of pharmaceutical innovation. As a guest faculty lecturer at the A4M event, John J Herr, R.Ph., brings his unique expertise and insights to the forefront of pharmaceutical compounding. His extensive knowledge and practical experience make him an invaluable resource for fellow professionals seeking to expand their understanding of the field. With a commitment to education and sharing knowledge, John's contributions as a lecturer reflect his ongoing dedication to advancing pharmaceutical compounding and improving patient care.